Naurex

Naurex

Naurex was a pharmaceutical company recognized for its innovative work in developing treatments for central nervous system disorders. The company's main focus was on developing therapies to address the challenges of depression and other related disorders.

Overview

Naurex aimed to create novel therapies that targeted the NMDA receptor, a critical player in neurologic function. Their work was especially significant given the increasing global burden of depression and the limitations of existing treatments.

History

• 2001: Naurex was founded with the mission of revolutionizing the treatment of depression and related disorders.
• 2015: Allergan acquired Naurex, with a primary interest in its two lead products, rapastinel and NRX-1074.

Research and Development

• Rapastinel: A groundbreaking NMDA receptor modulator. Clinical trials demonstrated its potential as a rapid-acting antidepressant with a favorable side effect profile.
• NRX-1074: A next-generation compound following rapastinel, showing promise in both oral and intravenous formulations.

Achievements

• Secured Fast Track designation from the FDA for rapastinel.
• Successfully transitioned its lead compounds into late-stage clinical trials.

Challenges

• While rapastinel showed promise in early trials, subsequent studies by Allergan revealed mixed results, leading to adjustments in its development strategy.

Legacy

Naurex's pioneering work in targeting the NMDA receptor paved the way for further research into novel treatments for depression. Its legacy remains evident in ongoing efforts to refine and expand upon its initial discoveries.

See Also

• Pharmaceutical industry
• Central nervous system
• Depression
• Clinical trial
• NMDA receptor

References

• [1] "Naurex: A Pioneer in Depression Treatment". Journal of Psychopharmacology.
• [2] "The Promise and Challenges of Rapastinel". CNS Drug Reviews.
• [3] "The Acquisition of Naurex: Strategic Implications". Pharmaceutical Business Review.

External Links

• [Naurex Historical Archive]
• [Allergan's Continued Work on Rapastinel]

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.